Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue
Phase 2
Terminated
- Conditions
- Metastatic Breast CancerFatigue
- First Posted Date
- 2016-01-01
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- Meriyana Bio Inc.
- Target Recruit Count
- 3
- Registration Number
- NCT02645175